Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia

Published:2016-12-14 Issue:7 Volume:64 Page:e26395
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Svahn Thommy¹,Mellgren Karin¹,Harila-Saari Arja²,Åsberg Ann³,Kanerva Jukka⁴,Jónsson Ólafur⁵,Vaitkeviciene Goda⁶,Stamm Mikkelssen Torben⁷,Schmiegelow Kjeld⁸,Heldrup Jesper⁹

Affiliation:

1. Department of Pediatrics; Sahlgrenska Academy, University of Gothenburg; Gothenburg Sweden

2. Department of Women's and Children's Health; Karolinska Institutet and Astrid Lindgren Children's Hospital, Karolinska Hospital; Stockholm Sweden

3. Pediatric Department, St. Olavs Hospital; Trondheim University Hospital; Trondheim Norway

4. Children's Hospital; Helsinki University Central Hospital and University of Helsinki; Helsinki Finland

5. Children's Hospital; Landspítali University Hospital; Reykjavik Iceland

6. Children's Hospital; Affiliate of Vilnius University Hospital Santariskiu Klinikos and Vilnius University; Vilnius Lithuania

7. Department of Pediatrics; Aarhus University; Denmark

8. Department of Pediatrics and Adolescent Medicine; Rigshospitalet; Copenhagen Denmark

9. Department of Pediatrics; Skåne University Hospital; Lund Sweden

Funder

Barncancerfonden

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Age- and sex-specific incidence of childhood leukaemia by immunophenotype in the Nordic countries;Hjalgrim;J Natl Cancer Inst,2003

2. Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor;Goldin;Nature,1966

3. The pharmacology and clinical use of methotrexate;Jolivet;N Engl J Med,1983

4. Understanding and managing methotrexate nephrotoxicity;Widemann;Oncologist,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solid-phase extraction coupled to automated centrifugal microfluidics SERS: Improving quantification of therapeutic drugs in human serum;Biosensors and Bioelectronics;2024-12

2. The Effect of Dextrose Hypotonic vs Saline Hydration on Methotrexate-Induced Nephrotoxicity in Male and Female Rats;Advanced Biomedical Research;2024-02

3. A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK;Health Science Reports;2024-01

4. Methotrexate level discrepancy post‐glucarpidase: A pediatric case series and review of literature;Pediatric Blood & Cancer;2023-12-27

5. Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy;Biomedicine & Pharmacotherapy;2023-10